Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Y chromosome" patented technology

The Y chromosome is one of two sex chromosomes (allosomes) in mammals, including humans, and many other animals. The other is the X chromosome. Y is normally the sex-determining chromosome in many species, since it is the presence or absence of Y that typically determines the male or female sex of offspring produced in sexual reproduction. In mammals, the Y chromosome contains the gene SRY, which by default triggers male development. The DNA in the human Y chromosome is composed of about 59 million base pairs. The Y chromosome is passed only from father to son. With a 30% difference between humans and chimpanzees, the Y chromosome is one of the fastest-evolving parts of the human genome. To date, over 200 Y-linked genes have been identified. All Y-linked genes are expressed and (apart from duplicated genes) hemizygous (present on only one chromosome) except in the cases of aneuploidy such as XYY syndrome or XXYY syndrome.

Method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of pregnant woman

InactiveCN105063181AEfficient and specific captureMicrobiological testing/measurementDiseaseRed blood cell
The invention discloses a method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of a pregnant woman. The method comprises the following steps: 1, preprocessing fresh pregnant woman maternal peripheral blood: separating and enriching monocytes containing fetal nucleated red blood cells from maternal peripheral whole blood through a density gradient centrifugation technology; 2, capturing cells: adding a separated monocyte suspension to a substrate chip modified with an antibody, and carrying out standing capturing; and 3, identifying the sex of a fetus: identifying whether the nucleated red blood cells of the captured fetus contain Y chromosome or not by using an FISH probe technology (CSP-X / Y). The method for noninvasive antenatal diagnosis through separating fetal nucleated red blood cells from peripheral circulating blood of the pregnant woman can realize capture and identification of the fetal nucleated red blood cells from the maternal peripheral circulating blood, and allows the FISH analysis to be directly carried out in order to realize noninvasive antenatal diagnosis of the sex or 21-Trisomy syndrome and other chromosome diseases of the fetus.
Owner:石莹

Detection kit for human Y-chromosomal microdeletion and application of detection kit

The invention provides a multi-PCR amplification system and detection kit for human Y-chromosomal microdeletion. The system comprises amplification primers comprising following loci with the corresponding sequences from SEQ ID No.1 to SEQ ID No.40, wherein the loci comprise 15 Y-chromosomal microdeletion loci (4 in the AZFa region, 4 in the AZFb region, 5 in the AZFc region and 2 in AZFd region),3 sample molecular tag loci (two X-STR loci and one autosomal locus) and 2 gender quality control loci (SRY, ZFX/Y). The 15 Y-chromosomal microdeletion loci use sequence tag loci (STS) specific primers, the 3 sample molecular tag loci use length polymorphism primers, and the 2 gender quality control loci use STS specific primers (EAA/EMQN Y-chromosomal microdeletion related aboratory optimal handbook recommendation detection loci, 2013). The primers are compatible with one another and can react in the same PCR amplification system. In addition, the invention further provides the detection kitcontaining an amplification primer composition container, a PCR reaction mother liquor container and a PCR auxiliary liquid container and application of the detection kit in human Y-chromosomal microdeletion non-diagnostic detection. After DNA extraction, target fragments of 20 genetic marker loci are amplified through a PCR reaction, the cost, labor and time can be remarkably saved, and the workefficiency is improved.
Owner:SHANGHAI GENEDISC BIOTECH CO LTD

A method for efficiently producing Nile tilapia high reproductive rate yy transformed female fish

The invention relates to a method for efficiently producing YY transformed females of Nile tilapia with a high reproductive rate. Firstly, the XY transformed females are mated with XY males or YY super males, and the offspring are simultaneously fertilized 5 days after fertilization. Soak in estrogen and androgen synthase inhibitors until 10 days after insemination; then feed high-dose hormone-supplemented feed for feminization for 3 months after juveniles open, and use Y chromosome-specific molecular markers to screen out sex chromosomes The transformed female fish with genotype YY were fed with normal feed until 6 months old; then at the age of 6-7 months, the YY transformed female fish were treated with low-dose hormone-supplemented feed, and were raised normally until sexual maturity; finally, the fertile YY transformed female fish were screened out . Fertile YY transformed females are mated with YY super males to establish YY maintenance lines and realize large-scale production of genetic all-male fry, which can significantly increase aquaculture production, reduce aquaculture costs, and reduce the use of hormones. In areas where tilapias invade and flood A large number of YY super male fish can be released for biological control.
Owner:SOUTHWEST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products